《Table 2.Comparison of CTFC Value between Two Groups (Frame/s, ±s)》

《Table 2.Comparison of CTFC Value between Two Groups (Frame/s, ±s)》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Effect of Shexiang Tongxin Dropping Pills(麝香通心滴丸) on the Immediate Blood Flow of Patients with Coronary Slow Flow》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录

In the CSF group，the CTFC values obtained after sublingual administration of STDP were less than those before the medication（P<0.05，Figure 1）.

图表编号XD0049342800    严禁用于非法目的
绘制时间2019.05.01
作者WANG Sheng-huang、CHU Lin、XU Zhao、ZHOU Hong-lin、CHEN Jiang-fei、NING Huang-fu
绘制单位Department of Cardiovascular Medicine, Ningbo Hospital of Zhejiang University, Ningbo First Hospital、Department of Cardiovascular Medicine, Ningbo Hospital of Zhejiang University, Ningbo First Hospital、Department of Cardiovascular Medicine, Ningbo Hospita
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 2 Comparison of perioperative indicators between two groups》2019.04.20
  2. 《Table 2.Comparison of the vital signs and pain scores between the two groups》2019.01.01
  3. 《表2 两组血糖波动情况对比 (±s) Table 2 Comparison of blood glucose fluctuation between the two groups (±s)》2018.09.28
  4. 《表2 两组射频消融手术指标比较Table 2 Comparison of radiofrequency ablation parameters between the two groups》2018.06.01
  5. 《表2 两组住院情况比较 (±s) Table 2 Comparison of hospitalizations between two groups (±s)》2018.08.28
  6. 《表2 两组治疗效果对比Table 2 Comparison of therapeutic effects between two groups》2018.09.25
  7. 《表2 两组患者临床资料比较Table 2 Comparison of clinical data between two groups》2018.08.10
  8. 《表2 两组临床疗效比较[n=30, 例 (%) ]Table 2 Comparison of the efficacy between two groups[n=30, n (%) ]》2018.07.10
  9. 《表2 两组患者的疗效比较 (单位:例) Table 2 Comparison of the efficacy between two groups (unit:case)》2018.04.10
  10. 《表2 两组患者临床疗效比较Table 2 Comparison of the clinical curative effect between two groups》2018.01.10
  11. 《表2 2组患者血液学毒性比较 (n, %) Table 2 Comparison of hematology toxicity between the two groups (n, %)》2018.09.28
  12. 《表2 2组患者的临床疗效比较 (n, %) Table 2 Comparison of clinical efficacy between two groups (n, %)》2018.09.28
  13. 《Table 2 Comparison of clinical efficacy between two groups (n, %)》2018.06.17
  14. 《表2 2组治疗依从性的比较Table 2 Comparison of treatment compliance between two groups》2018.02.20
  15. 《表2 2组瘤体重量比较 (±s) Table 2 Comparison of tumor weight between two groups (±s)》2018.02.20
  16. 《表2 两组患者凝血酶原情况对比 (±s) Table 2 Comparison of prothrombin between the two groups (±s)》2018.01.25
  17. 《表2 两组术中相关指标对比 (±s) Table 2 Comparison of intraoperative indexes between the two groups (±s)》2018.01.25
  18. 《表2 两组患者的诊断效果对比 (%) Table 2 Comparison of diagnostic effects between the two groups (%)》2018.08.01
  19. 《表2 两组患者手术相关资料比较Table 2 Comparison of surgical related data between the two groups》2018.08.18
  20. 《表2 两组患者术后失血情况比较Table 2 Comparison of postoperative blood loss between two groups》2018.08.18

随机翻阅

《表1 2 0 1 9 年安徽省各市主要指标》 《表4 多元回归结果分析：战略控制视角下董事会特征对会计信息披露质量的影响》 《表3 LA和YC对绵羊营养物质消化利用的影响》 《表5 管理层薪酬与企业可持续发展》 《表4 潜在变量间相关系数与AVE平方根》 《表3 三种香型牛油脂肪酸的组成及相对含量》 《表2 我国心衰患者患病人数及住院费用估算结果》 《表1 两组患者临床疗效比较 (例)》 《表1 原大庄村5个措哇人口在9个自然村的分布情况》 《表1 2组患者的一般资料比较 (±s)》